サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1126250

凍結乾燥注射剤の2028年までの市場予測-包装タイプ、デリバリータイプ、適応症、エンドユーザー別の世界分析

Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Packaging, Type of Delivery, Indication, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 200 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
凍結乾燥注射剤の2028年までの市場予測-包装タイプ、デリバリータイプ、適応症、エンドユーザー別の世界分析
出版日: 2022年08月10日
発行: The Insight Partners
ページ情報: 英文 200 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の凍結乾燥注射剤市場は、2021年の27億1942万米ドルから2028年には40億127万米ドルに達すると予測され、2022年から2028年までのCAGRは5.8%と予測されています。

研究受託製造サービスに対する需要の増加、医薬品の承認取得の増加、生物製剤の需要拡大が市場成長の原動力となっています。しかし、製品のリコールが多いことが市場成長の妨げになっています。

凍結乾燥または凍結乾燥は、氷の結晶を水蒸気に昇華させることで行われます。凍結乾燥は、負の温度、製品の活性、安定性に基づくプロセスであり、製品へのダメージを制限し、分子の劣化を避けながら有効成分を保持することができます。このように、フリーズドライは医薬品・診断分野で特に人気があります。凍結乾燥注射剤の品質向上と保存期間の延長は、メーカーが製品製造に凍結乾燥プロセスを導入する成長機会を生み出しました。受託製造や研究サービスには大きな需要があり、エンドユーザーに高品質の製品を提供するために凍結乾燥注射剤を提供しています。

さらに、多くの製薬会社が研究開発などの中核的な能力に再集中しているため、社内製造能力の切り離しが行われ、製造のための研究開発受託サービス（CRAM）の需要が高まっています。さらに、CRAMは、マルチサイト供給戦略やバックアップ能力を持つ製薬会社に追加サイトを提供することで、供給不足のリスクを軽減する重要な役割を担っています。例えば、2019年、Samsung BiologicsとGI Innovationは免疫化学療法に関する契約を締結しました。この契約では、Samsung Biologicsは細胞株の開発から第I相原薬製造までのサービスを提供しました。

さらに、安全な輸送や医薬品の保存期間の延長など、凍結乾燥注射剤が提供する利点により、世界の多くの企業で凍結乾燥技術の採用が進みました。

COVID-19パンデミックの世界の影響は、いくつかの市場にわたって示されています。厳しい封鎖と移動制限のため、臨床試験は一時的に停止されました。ヘルスケア分野では、主にCOVID-19患者の治療とCOVID-19ワクチンの開発に焦点が移されました。これらの要因が、パンデミックの初期段階における市場の成長にプラスの影響を与えました。

COVID-19の流行のピーク時には、患者の治療に使用される抗ウイルス薬であるレムデシビルの需要が異常に高まりました。凍結乾燥注射剤市場のメーカーは、COVID-19のような脆弱性を回避するために十分なサプライチェーンを維持し、将来に備えています。ギリアド・サイエンシズをはじめとする大手製薬会社は、入院中のCOVID-19患者の治療にレムデシビルを使用することについて、米国FDAから緊急使用承認（EUA）を取得しました。さらに、2020年5月、ギリアド・サイエンシズ社は、シプラ社が製造・販売するレムデシビルの後発品「CIPREMI」の任意非独占ライセンスをシプラ社に拡大しました。企業は、激動する市場環境に対応するため、BFSI業界が与える政府プログラムや融資制度を活用し、業務の効率化を図っています。例えば、2020年5月、米国政府は、パンデミックの中で国の医薬品供給を強化するために、潜在的に8億1200万米ドル相当の米国の後発医薬品メーカーグループと協定を締結しました。このように、COVID-19のパンデミックによる医薬品需要の増大は、世界の凍結乾燥注射剤市場を強化したのです。

地域別インサイト

世界の凍結乾燥注射剤市場では、北米が最大のシェアを占めており、アジア太平洋地域は最も急速に成長している地域です。北米の市場は、安全な包装と保存期間の延長を目的とした凍結乾燥注射剤の需要の増加、COVID-19の大流行による医薬品生産の増加、ヘルスケア産業における研究開発の高まりにより、予測期間中に成長すると予想されます。

2022年から2028年の間に、アジア太平洋地域は世界の凍結乾燥注射剤市場で最も高いCAGRを記録すると見られています。同地域の市場は、中国、インド、日本を含む国々で今後数年間に大きく成長することが予想されます。バイオテクノロジー、製薬、生物製薬企業による投資の増加による研究開発活動の活発化や、さまざまな分野での凍結乾燥注射剤の用途の増加が、アジア太平洋地域における凍結乾燥注射剤の需要を促進している要因の1つとなっています。

包装の種類に基づく洞察

世界の凍結乾燥注射剤市場は、包装の種類に基づいて、シングルユースバイアル、ポイントオブケアリコンストラクション、特殊包装に区分されます。2021年には、シングルユースバイアルセグメントが最大の市場シェアを占め、一方、特殊包装セグメントは予測期間中に6.7%の最高のCAGRを記録すると予測されます。

配送のタイプに基づく洞察

送達のタイプに基づいて、世界の凍結乾燥注射剤市場は、プレフィルド希釈剤シリンジ、独自の再構成デバイス、シングルステップ・デバイス、マルチステップ・デバイスに区分されます。プレフィルド希釈剤シリンジセグメントは2021年に最大の市場シェアを占め、予測期間中に6.3%の最高のCAGRを記録すると予測されます。

適応症に基づく洞察

適応症に基づき、世界の凍結乾燥注射剤市場は、代謝および腫瘍疾患、感染症、自己免疫疾患、その他の適応症に区分されます。代謝・腫瘍疾患分野は2021年に最大の市場シェアを占め、予測期間中に6.2%の最高CAGRを記録すると予測されています。

エンドユーザーベースの洞察

エンドユーザーに基づいて、世界の凍結乾燥注射剤市場は、病院、外来手術センター、専門クリニック、その他に区分されます。2021年には、病院セグメントが最大の市場シェアを占めました。しかし、専門クリニックセグメントは、予測期間中に市場で最も高いCAGR 6.3%を記録すると推定されます。

世界保健機関（WHO）、Globocan、世界銀行データ、国立保健サービス（NHS）、国立医学図書館（NLM）、医療機器振興協会などは、世界の凍結乾燥注射剤市場に関するレポートを作成する際に参照した二次情報の一部です。

目次

第1章 イントロダクション

  • 調査対象範囲
  • インサイトパートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • 凍結乾燥注射剤の世界市場-包装タイプ別
    • 凍結乾燥注射剤の世界市場：投与タイプ別
    • 凍結乾燥注射剤の世界市場- 効能別
    • 凍結乾燥注射剤の世界市場：エンドユーザー別
    • 凍結乾燥注射剤の世界市場- 地域別

第2章 凍結乾燥注射剤市場-主要なポイント

第3章 調査手法

  • 調査対象
  • 2次調査
  • 1次調査

第4章 凍結乾燥注射剤市場- 市場情勢

  • PEST分析
    • 北米PEST分析
    • 欧州PEST分析
    • アジア太平洋地域のPEST分析
    • 中東・アフリカPEST分析
    • 中南米PEST分析
  • 専門家の見解

第5章 凍結乾燥注射剤市場-主要な市場力学

  • 市場促進要因
    • 研究開発受託製造サービスに対する需要の増加
    • 医薬品の承認取得の増加
    • 生物製剤の需要増加
  • 市場抑制要因
    • 製品のリコール
  • 市場機会
    • 凍結乾燥注射剤のパイプラインの拡大
  • 今後の動向
    • 凍結乾燥パッケージングの先進性
  • インパクト分析

第6章 凍結乾燥注射剤市場：世界分析

  • 凍結乾燥注射剤の世界市場：収益と予測・分析
    • 凍結乾燥注射剤の世界市場：収益予測と分析
    • 凍結乾燥注射剤市場：ポテンシャル分析（地域別）
  • 比較企業分析
  • 成長戦略分析
  • 凍結乾燥注射剤市場における主要企業の市況分析
  • 主要企業の業績
      • Baxter International
      • ニプロ
  • 市場シェア分析
  • 凍結乾燥製剤のトップ3製品（ASP）（2021年）

第7章：凍結乾燥注射剤市場の分析- 包装形態別

  • 凍結乾燥注射剤市場の包装タイプ別収益シェア（2021年、2028年）
  • 単回使用バイアル
  • ポイントオブケアレコンストラクション
  • 特殊包装

第8章 凍結乾燥注射剤市場の分析- 配達タイプ別

  • 凍結乾燥注射剤市場のデリバリータイプ別収益シェア（2021年、2028年）
  • プレフィルド希釈剤シリンジ
  • シングルステップデバイス
  • 独自の再構成デバイス
  • マルチステップデバイス

第9章 凍結乾燥注射剤市場の分析- 適応症別

  • 凍結乾燥注射剤市場の適応症別収益シェア（2021年、2028年）
  • 代謝性疾患および腫瘍性疾患
  • 感染症
  • 自己免疫疾患
  • その他の適応症

第10章 凍結乾燥注射剤市場- エンドユーザー別

  • 凍結乾燥注射剤市場：エンドユーザー別、2021年、2028年（%）
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他のエンドユーザー

第11章 2028年までの凍結乾燥注射剤市場の収益と予測- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中南米地域
    • ブラジル
    • アルゼンチン
    • その他の中南米地域
  • 中東・アフリカ
    • 中東・アフリカ地域
      • 南アフリカ
      • サウジアラビア
      • UAE
      • その他中東地域

第12章 COVID-19のパンデミックが世界の凍結乾燥注射剤市場に与える影響

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東とアフリカ

第13章 凍結乾燥注射剤市場-業界情勢

  • 凍結乾燥注射剤市場の成長戦略
  • 無機的な成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • Baxter
  • Nipro
  • Curia Global, Inc.
  • Recipharm AB
  • Vetter Pharma
  • Jubilant HollisterStier（Jubilant Pharma Limited）
  • Aristopharma Ltd.
  • CordenPharma International
  • Credence MedSystems, Inc.
  • S.G. Biopharm Pvt. Ltd.

第15章 付録

  • インサイト・パートナーズについて
  • 用語解説
図表

List Of Tables

  • Table 1. Top 3 Lyophilized Drug Products ((Global Average Selling Price (ASP)) (2021)
  • Table 2. North America Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Europe: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 19. Europe: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 20. Europe: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 21. Europe: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 22. Germany: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 23. Germany: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 24. Germany: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 25. Germany: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 26. UK: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 27. UK: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 28. UK: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 29. UK: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 30. France: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 31. France: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 32. France: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 33. France: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 34. Italy: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 35. Italy: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 36. Italy: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 37. Italy: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 38. Spain: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 39. Spain: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 40. Spain: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 41. Spain: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 42. Rest of Europe: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 43. Rest of Europe: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 44. Rest of Europe: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 45. Rest of Europe: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 46. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million).
  • Table 47. Asia Pacific: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Asia Pacific: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 51. China: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. China: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 55. India: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. India: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. India: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 59. Japan: Lyophilized Injectable Market, by Type of Delivery- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Japan: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Japan: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 63. South Korea: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Korea: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Korea: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 67. Australia: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Australia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Australia: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
  • Table 71. Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Asia Pacific: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
  • Table 75. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
  • Table 76. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
  • Table 77. South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
  • Table 78. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 79. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 80. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 81. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 82. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 83. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 84. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 85. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 86. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
  • Table 87. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Delivery (US$ Million)
  • Table 88. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
  • Table 89. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 90. Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 91. Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 92. Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 93. Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 94. South Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 ( US$ 'Million)
  • Table 95. South Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 96. South Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 97. South Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 98. Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 99. Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 100. Saudi Arabia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 101. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 102. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 103. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 104. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 105. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 106. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 107. Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 108. Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 109. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ 'Million)
  • Table 110. Recent Inorganic Growth Strategies in the Lyophilized Injectable Market
  • Table 111. Recent Organic Growth Strategies in the Lyophilized Injectable Market
  • Table 112. Glossary of Terms, Lyophilized Injectable Market

List Of Figures

  • Figure 1. Lyophilized Injectable Market Segmentation
  • Figure 2. Lyophilized Injectable Market - By Geography
  • Figure 3. Lyophilized Injectable Market Overview
  • Figure 4. Single-Use Vials Segment Held Largest Share by Type of Packaging in Lyophilized Injectable Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Lyophilized Injectable Market, by Geography (US$ Million)
  • Figure 7. Global Lyophilized Injectable Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Lyophilized Injectable Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Lyophilized Injectable Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Lyophilized Injectable Market- Revenue Forecast And Analysis - 2022 - 2028
  • Figure 18. Global Lyophilized Injectable Market - Market Potential Analysis, by Region
  • Figure 19. Global Lyophilized Injectable Market - Comparative Company Analysis
  • Figure 20. Global Lyophilized Injectable Market - Growth Strategy Analysis
  • Figure 21. Market Positioning Analysis of Key Players in Global Lyophilized Injectable Market
  • Figure 22. Market Share Analysis of Key Players in Global Lyophilized Injectable Market
  • Figure 23. Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
  • Figure 24. Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
  • Figure 28. Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
  • Figure 33. Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
  • Figure 38. Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. North America: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 43. North America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 45. US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Europe: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ 'Million)
  • Figure 49. Europe: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 50. Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 51. Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 52. UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 53. France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 54. Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 55. Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 56. Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 57. Asia Pacific Lyophilized Injectable Market Overview, by Country (2021)
  • Figure 58. Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 60. China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 61. India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 62. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 63. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 64. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 65. Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. South and Central America Lyophilized Injectable Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 67. South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 69. Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Middle East and Africa: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ 'Million)
  • Figure 73. Middle East and Africa: Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 74. Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  • Figure 75. South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 76. Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 77. UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 78. Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
  • Figure 79. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 80. Impact Of COVID-19 Pandemic in Europe Country Markets
  • Figure 81. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 82. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 83. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 84. Growth Strategies in the Lyophilized Injectable Market
目次
Product Code: TIPRE00004411

The global lyophilized injectable market is projected to reach US$ 4,001.27 million by 2028 from US$ 2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.

The increasing demand for contract research manufacturing services, rising approvals of pharmaceuticals, and growing demand for biologics drive the growth of the market. However, high product recalls hamper the market growth.

Freeze drying, or lyophilization, consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures, the product's activity, and stability, along with active ingredients that are retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in the pharmaceutical & diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs created growth opportunities for manufacturers to implement the lyophilization process in product manufacturing. The contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to the end users.

Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is propelling the demand for contract research manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. For instance, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under the agreement, Samsung Biologics provided services ranging from the development of cell line to the production of Phase I drug substances.

Furthermore, the advantages offered by the lyophilized injectables, such as safe transit and extended pharmaceutical storage life, increased the adoption of the lyophilization technique by many enterprises globally.

The global impacts of COVID-19 pandemic are witnessed across several markets. Due to stringent lockdown and movement restrictions, clinical trials were temporarily halted. In the healthcare sector, the focus was shifted primarily to the treatment of COVID-19 patients and the development of the COVID-19 vaccine. All these factors had a positive impact on market growth in the initial phase of pandemic.

There was an unusual demand for Remdesivir, an antiviral medicine used to treat patients, during the peak of the COVID-19 outbreak. Manufacturers in the lyophilized injectables market are preparing for the future by keeping adequate supply chains to avoid any COVID-19-like vulnerabilities. Gilead Sciences and other big pharma companies received an Emergency Use Authorization (EUA) by the US FDA for the use of remdesivir for the treatment of hospitalized COVID-19 patients. Further, in May 2020, Gilead Sciences Inc. extended a voluntary nonexclusive license to Cipla to manufacture and market Cipla's generic version of remdesivir called CIPREMI. Companies are utilizing government programs and financing schemes given by the BFSI industry to streamline their operations in response to turbulent market conditions. For instance, in May 2020, the US government entered an agreement with a group of American generic medicine manufacturers potentially worth US$ 812 million to bolster the country's drug supply amid the pandemic. Thus, the growing demand for drugs due to the COVID-19 pandemic bolstered the global lyophilized injectable market.

Geography-Based Insights

North America holds the largest share of the global lyophilized injectable market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the increasing demand for lyophilized injectables for safe packaging and prolonged shelf life, growing pharmaceutical production due to the COVID-19 pandemic, and rising research and development in the healthcare industry.

During 2022-2028, Asia Pacific is likely to register the highest CAGR in the global lyophilized injectable market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The growing research & development activities due to the increase in the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and rising applications of lyophilized injectable drug in various fields are among the factors propelling the demand for lyophilized injectables in Asia Pacific.

Type of Packaging- Based Insights

The global lyophilized injectable market, based on type of packaging, is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. In 2021, the single-use vials segment accounted for the largest market share, whereas the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.

Type of Delivery- Based Insights

Based on type of delivery, the global lyophilized injectable market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.3% during the forecast period.

Indication- Based Insights

Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.2% during the forecast period.

End User- Based Insights

Based on end user, the global lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021. However, the specialty clinics segment is estimated to register the highest CAGR of 6.3% in the market during the forecast period.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Association for the Advancement of Medical Instrumentation are a few secondary sources referred to while preparing the report on the global lyophilized injectable market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the lyophilized injectable market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the lyophilized injectable market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Lyophilized Injectable Market - By Type of Packaging
    • 1.3.2 Global Lyophilized Injectable Market - By Type of Delivery
    • 1.3.3 Global Lyophilized Injectable Market - By Indication
    • 1.3.4 Global Lyophilized Injectable Market - By End User
    • 1.3.5 Global Lyophilized Injectable Market - By Geography

2. Lyophilized Injectable Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Lyophilized Injectable Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. Lyophilized Injectable Market- Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Contract Research Manufacturing Services
    • 5.1.2 Rising Approvals of Pharmaceuticals
    • 5.1.3 Increasing Demand of Biologics
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
  • 5.4 Future Trends
    • 5.4.1 Advancement in Lyophilized Packaging
  • 5.5 Impact Analysis

6. Lyophilized Injectable Market- Global Analysis

  • 6.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
    • 6.1.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
    • 6.1.2 Global Lyophilized Injectable Market - Market Potential Analysis, by Region
  • 6.2 Comparative Company Analysis
  • 6.3 Growth Strategy Analysis
  • 6.4 Market Positioning Analysis of Key Players in Lyophilized Injectable Market
  • 6.5 Performance of Key Players
      • 6.5.1.1 Baxter International
      • 6.5.1.2 Nipro
  • 6.6 Market Share Analysis
  • 6.7 Top 3 Lyophilized Drug Products (ASP) (2021)

7. Lyophilized Injectable Market Analysis - By Type of Packaging

  • 7.1 Overview
  • 7.2 Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
  • 7.3 Single-use vials
    • 7.3.1 Overview
    • 7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Point-of-Care Reconstitution
    • 7.4.1 Overview
    • 7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Specialty Packaging
    • 7.5.1 Overview
    • 7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

8. Lyophilized Injectable Market Analysis - By Type Of Delivery

  • 8.1 Overview
  • 8.2 Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
  • 8.3 Prefilled Diluent Syringes
    • 8.3.1 Overview
    • 8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Single Step Devices
    • 8.4.1 Overview
    • 8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Proprietary Reconstitution Devices
    • 8.5.1 Overview
    • 8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Multi-Step Devices
    • 8.6.1 Overview
    • 8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

9. Lyophilized Injectable Market Analysis - By Indication

  • 9.1 Overview
  • 9.2 Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
  • 9.3 Metabolic and Oncology Conditions
    • 9.3.1 Overview
    • 9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Infectious Diseases
    • 9.4.1 Overview
    • 9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Autoimmune Diseases
    • 9.5.1 Overview
    • 9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Other Indications
    • 9.6.1 Overview
    • 9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

10. Lyophilized Injectable Market -By End User

  • 10.1 Overview
  • 10.2 Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Specialty Clinics
    • 10.5.1 Overview
    • 10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Other End Users
    • 10.6.1 Overview
    • 10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

11. Lyophilized Injectable Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 11.1 North America: Lyophilized Injectable Market
    • 11.1.1 Overview
    • 11.1.2 North America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.1.3 North America: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
    • 11.1.4 North America: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    • 11.1.5 North America: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    • 11.1.6 North America: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
    • 11.1.7 North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.1.7.1 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.3 US: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.1.4 US: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.1.5 US: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.1.6 US: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.1.7.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.3 Canada: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.2.4 Canada: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.2.5 Canada: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.2.6 Canada: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.1.7.3 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.3 Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
        • 11.1.7.3.4 Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.1.7.3.5 Mexico: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.1.7.3.6 Mexico: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  • 11.2 Europe: Lyophilized Injectable Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    • 11.2.3 Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    • 11.2.4 Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    • 11.2.5 Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    • 11.2.6 Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
    • 11.2.7 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.2.7.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.1.5 Germany: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.2.5 UK: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.2.6 UK: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.3 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.3.5 France: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.3.6 France: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.4 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.4.6 Italy: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.5 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.5.6 Spain: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.2.7.6 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.2.7.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
        • 11.2.7.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
        • 11.2.7.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.2.7.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  • 11.3 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts To 2028
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    • 11.3.3 Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    • 11.3.4 Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    • 11.3.5 Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    • 11.3.6 Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
    • 11.3.7 Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.3.7.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.1.5 China: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.1.6 China: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.2.5 India: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.2.6 India: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.3.6 Japan: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.7.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.5.6 Australia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  • 11.4 South and Central America Lyophilized Injectable Market
    • 11.4.1 Overview
    • 11.4.2 South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
    • 11.4.3 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
    • 11.4.4 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
    • 11.4.5 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
    • 11.4.6 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
    • 11.4.7 South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.4.7.1 Brazil: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Brazil Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.3 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.1.4 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.1.5 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.1.6 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 11.4.7.2 Argentina: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Argentina Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.3 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.2.4 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.2.5 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.2.6 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
      • 11.4.7.3 Rest of the South and Central America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 Rest of the South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.3 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
        • 11.4.7.3.4 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
        • 11.4.7.3.5 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
        • 11.4.7.3.6 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
  • 11.5 Middle East & Africa Lyophilized Injectable Market Revenue and Forecasts To 2028
    • 11.5.1 Overview
    • 11.5.2 Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    • 11.5.3 Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    • 11.5.4 Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    • 11.5.5 Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    • 11.5.6 Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
    • 11.5.7 Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
      • 11.5.7.1 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.3 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.3.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.3.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.3.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.3.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
      • 11.5.7.4 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.4.1 Overview
        • 11.5.7.4.2 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
        • 11.5.7.4.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
        • 11.5.7.4.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
        • 11.5.7.4.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
        • 11.5.7.4.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)

12. Impact of COVID-19 Pandemic on Global Lyophilized Injectable Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Lyophilized Injectable Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Lyophilized Injectable Market
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Baxter
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Nipro
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Curia Global, Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Recipharm AB
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Vetter Pharma
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Jubilant HollisterStier (Jubilant Pharma Limited)
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Aristopharma Ltd.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 CordenPharma International
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Credence MedSystems, Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 S.G. Biopharm Pvt. Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms